Literature DB >> 27073337

Intravenous Clonazepam in Status Epilepticus.

Mohamad Koubeissi.   

Abstract

Entities:  

Year:  2016        PMID： 27073337      PMCID： PMC4822737          DOI： 10.5698/1535-7511-16.2.89

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  6 in total

1.  Efficacy of nonvenous medications for acute convulsive seizures: A network meta-analysis.

Authors:  Ravindra Arya; Harsh Kothari; Zongjun Zhang; Baoguang Han; Paul S Horn; Tracy A Glauser
Journal:  Neurology       Date:  2015-10-28       Impact factor: 9.910

2.  Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison.

Authors:  Vincent Alvarez; Jong Woo Lee; Frank W Drislane; M Brandon Westover; Jan Novy; Barbara A Dworetzky; Andrea O Rossetti
Journal:  Epilepsia       Date:  2015-07-03       Impact factor: 5.864

3.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

4.  Predictors of outcome in refractory status epilepticus.

Authors:  Sara E Hocker; Jeffrey W Britton; Jayawant N Mandrekar; E F M Wijdicks; Alejandro A Rabinstein
Journal:  JAMA Neurol       Date:  2013-01       Impact factor: 18.302

5.  In-hospital mortality of generalized convulsive status epilepticus: a large US sample.

Authors:  Mohamad Koubeissi; Amer Alshekhlee
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

6.  Benzodiazepine pharmacology and central nervous system-mediated effects.

Authors:  Charles E Griffin; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2013
  6 in total
  1 in total

1.  Development of a Cyclodextrin-Based Mucoadhesive-Thermosensitive In Situ Gel for Clonazepam Intranasal Delivery.

Authors:  Marzia Cirri; Francesca Maestrelli; Giulia Nerli; Natascia Mennini; Mario D'Ambrosio; Cristina Luceri; Paola Angela Mura
Journal:  Pharmaceutics       Date:  2021-06-26       Impact factor: 6.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.